Wilmington, DE, United States
Ultra Supplement LLC recalls
1 recall recorded since 2018, most recently on 21 July 2022. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)1
Terminated Class I Drugs
- Recall started
- 21 July 2022
- Terminated
- 16 October 2023
- Reason
- Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
- Distribution
- Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1350-2022
- SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.